Roche Holding AG (ROG.S)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|52||2013||Chairman of the Corporate Executive Committee, Chief Executive Officer, Executive Director|
|58||2011||Non-Executive Independent Chairman of the Board|
|89||2004||Honorary Chairman of the Board|
|61||Non-Executive Independent Vice Chairman of the Board|
|52||2011||Member of the Corporate Executive Committee, Chief Financial Officer, Information Technology Officer|
- Roche defeats investor lawsuit alleging undisclosed drug researcher conflict
- Roche's combo lymphoma treatment wins U.S. FDA approval
- CORRECTED-UPDATE 3-Roche's combo lymphoma treatment wins U.S. FDA approval
- BRIEF-Roche: Rituximab Phase III Study Met Primary Endpoint
- BRIEF-FDA Grants Priority Review To Roche’S Rituximab In Children With Blood Vessel Disorders